The Czech Republic is one of the European countries where the increasing resistance especially in Gram-negative pathogens has become a serious issue. The bacterial resistance is surveyed in community and hospital-acquired pathogens through the national (respiratory and urinary tract infections) and European (EARS-Net) projects. The surveillance of resistance is performed and coordinated by National reference laboratory for antibiotics located at the National Institute of Public Health.
National AMR research program and activities
The Czech Action Plan for the National AMR research program includes six pillars: Surveillance, Responsible Use of Antibiotics, Awareness, Systematic Infrastructure, Prevention, and Research and Innovations.
- National AMR research program 2019-2022
- Conception of medical Research until 2020: Program for support of the medical applied Research and Development 2015-2022
- Public tenders
National AMR research calls
- JPIAMR Transnational Call 2017; Comparison of prevention, control and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches
- JPIAMR Transnational Call 2018; Innovations against antibiotic-resistant bacteria: new targets, compounds and tools
- JPIAMR Transnational Call 2019; Diagnostics and Surveillance of Antimicrobial Resistance: Development of tools, technologies and methods for global use
Other national activities
- Workshop on Antimicrobial resistence and Infections, 26 November 2018, Prague
- Conference on European Antibiotics Day, 20 November 2018, Prague
Management Board representative
- Daniel Hanspach, Ministry of Education, Youth and Sports